The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Is there a reason the company would hold of until the last few days to release the results ? Or would they be expected to announce them even if they are ahead of schedule ? I will hold of my concern until the end of the month when they said it would be done .
The fact that fortacin got through the euro trials should stand us in good stead now with USA surely , especially in that the product has been sold for a period of time with no negative reports coming out regarding bad side effects etc . Maybe fda trials have a very different criteria to achieve .
I agree with all the years of “ we are in talks with potential partners…” it gets very tiring as I have always thought how can talks take so many years to come to decisions , unless like you said potential partners would be waiting for full end point of all trials . I have previously scoured the internet in research of drug trials and partnership points, but most of the data I could find was for life threatening conditions and they could be taken out as early as pre clinical or phase 1/2 . As fortacin is a unique entity in the medical world and not a life saving product, it’s difficult to gage an idea of what it’s licensees or partners would want before getting involved . The fact we have no idea about user data in Europe , such as repeat orders or general feedback from users also makes it difficult to gather to much knowledge about regular users thoughts of the product .
Yes Italian it really is useless trying to predict the movements in Regents price. after many years you would hope that the stars may align in some way and deliver a spate of good news but as we have seen before there are a lot of factors that come into play so it is unpredictable, all significant lth can do is wait and see but i appreciate getting the thoughts of others here even if sometimes it is not what you want to hear haha
interesting to hear your thoughts italian so thanks . I personally can't see how a prediction of positive results could be factored in to the current price as it is.
strong phase 2 results would be a really strong sign moving forward and therefore if it was to happen i believe we could see another volume and price spike. After all the years of announcements from the company stating that they are in discussions with potential partners it would be nice if things could go smoothly for us for a change and a positive outcome from the trials can be reached at some point relatively soon . I don't know how USA partners would look at it whether they would want completion of all trials or not before joining the party, as other territory deals did come before completion.
with regards to venturex it all depends on how the company play it I suppose, whether its a long or short term hold, now that the price has recovered significantly.
I no longer try and predict like you Italian due to roadblocks previously encountered.
no drop today so hopefully no bad news on the way . How significantly do you guys think the market will take any news over the next few weeks ?
I can’t get my head around it heimdel , vxr holding up well , the unknown is USA outcome i suppose. what do you mean by “off screen seller” ? Very frustrating
Very valid points bignose . The proof will be in the pudding , it will be about capitalising on news at the right time with the right pr I guess . Of course all this is an “if” right now regarding to news .
About venturex I agree it’s a legacy holding , but it is seriously boosting the value of the company on paper which you would expect would be recognised by the market in some degree but seems to go unnoticed .
If the product was to develop through trials it seems it would get a lot more exposure to people due to news outlets who would no doubt cover the story and the possiblity of medical companies and drs putting it forward.
in regard to the staff of the company, although a lot of negativity towards them on here at times which looking at the share price over last few years is understandable - and maybe I am looking through rose tinted glasses- but they are very experienced and if progress can happen, they may well be knowledgable enough to know how to capitalise on it .
Yeh blows my mind seeing the value on show right now when venturex is motoring and fortacin closer than ever to some big markets- if it can be done and given the green light. I understand we don’t know sales figures from places it’s currently available ,but it’s always been stated the USA is the main market with the way of the pharma world over there .
Exciting times maybe regarding venturex then. If the company can produce the goods with fortacin , it could add some serious value which hopefully would be recognised by the market
I read somewhere in an announcement regent have options to buy more shares of venturex at a certain price ? Has anyone done the maths to see what additional value this could add currently at venturex value ?
Looking at the chart of venturex right now is insane - 8% up again right now
Thanks Heimdel , can you explain the significance or reasoning for the amortization? I have read up on it but can’t comprehend it’s purposes fully, is it along the lines of a mortgage where the cost is spread out over time ? But I sense there are important differences that I could not gather from my reading
Great to see venturex powering ahead , no idea how long company plan to hold but copper market very buoyant- only a good thing for us .
Does anyone have a clue how long we should have to wait for the fda results in June or July ? Will we be told an outcome of p2 or just that results are either good or bad looking ?
Thanks again all
I appreciate the in depth analysis and thoughts Alq, even if they go against what LTH's would ever want. It is a medically researched fact that PE is one the most common problems in that area of health, so I have to disagree that there may not be demand but Fortacin must be shown/proved to be the lead treatment for people to use.
In regards to EU, you have a much better understanding than me of the processes involved so i can't comment too much, my thought is that Fortacin is not a very visible product that people would know about right now, and maybe that could change with more brand awareness from the holy grail us approval , and the boost in coverage if that was achieved from news outlets. This could result in a big increase maybe even outside the us.
If what you say is correct and maybe it is or it is not, I do not understand why the company would have persisted for so long , I believe they must have a very good understanding of the potential.
with regards to DLI I have no understanding apart from the fact that medical area is growing , and Venturex is a surprise that no shareholder would complain about even if it goes against the company's stated philosophy, because it has added some serious value at this stage.
Alq you seem to have a lot of knowledge in the area so appreciate your thoughts , even if could be viewed negatively you raise points . What are your thoughts for how this will play out ? Are you a holder here ?
Yes good points regarding venturex being a legacy holding...but if it’s boosting our market cap then it’s a good thing and can’t be viewed as a negative .
With regards to USA , if the results are good ,will there be more hoops to jump through before a potential partner may get involved ? Surely over all the years they have done their due diligence already on the capabilities of the product and it’s potential worth to them, if it can gain approval for use.
Can anyone explain the “locked in” phrase in the announcement regarding the USA results ? Don’t know what this signifies .
Heimdel I love the positivity! I seriously hope you are right , I keep belief from the fact staff have a track record of some successful deals and hopefully they can produce something special here even when hope is dwindling along for many years . I have read announcements for years and always stated USA partners is in discussion, I can only assume companies must have to wait for results from trials to get involved . Look at what venturex as done out of the blue , hopefully fortacin and deep longevity can follow suit !!
Bignose , you raise a lot of good valid points . I was looking at it in the sense of they have detailed moving forward regarding USA etc but nothing substantial in reality , I agree I found it strange venturex was featured first ... also deep longevity I still don’t know have a clue regarding game plan with it
Have to say I was expecting a bigger positive price reaction today due to updates I must give up from trying to predict how this market will react to news !!
this is no doubt positive announcement. fda signs look good, venturex value increase is mentioned. america has and always will be the main market by a long way and this update seems to signify progress.